These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo. Walling DM; Flaitz CM; Nichols CM; Hudnall SD; Adler-Storthz K J Infect Dis; 2001 Dec; 184(12):1499-507. PubMed ID: 11740724 [TBL] [Abstract][Full Text] [Related]
24. Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray. Loebel M; Eckey M; Sotzny F; Hahn E; Bauer S; Grabowski P; Zerweck J; Holenya P; Hanitsch LG; Wittke K; Borchmann P; Rüffer JU; Hiepe F; Ruprecht K; Behrends U; Meindl C; Volk HD; Reimer U; Scheibenbogen C PLoS One; 2017; 12(6):e0179124. PubMed ID: 28604802 [TBL] [Abstract][Full Text] [Related]
25. Predictors of chronic fatigue in adolescents six months after acute Epstein-Barr virus infection: A prospective cohort study. Pedersen M; Asprusten TT; Godang K; Leegaard TM; Osnes LT; Skovlund E; Tjade T; Øie MG; Wyller VBB Brain Behav Immun; 2019 Jan; 75():94-100. PubMed ID: 30261303 [TBL] [Abstract][Full Text] [Related]
26. Valacyclovir prevention of cytomegalovirus reactivation after heart transplantation: a randomized trial. Egan JJ; Carroll KB; Yonan N; Woodcock A; Crisp A J Heart Lung Transplant; 2002 Apr; 21(4):460-6. PubMed ID: 11927223 [TBL] [Abstract][Full Text] [Related]
27. Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific polyclonal immune response? Manian FA Clin Infect Dis; 1994 Sep; 19(3):448-53. PubMed ID: 7811864 [TBL] [Abstract][Full Text] [Related]
28. Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients. Malouf MA; Chhajed PN; Hopkins P; Plit M; Turner J; Glanville AR J Heart Lung Transplant; 2002 May; 21(5):547-54. PubMed ID: 11983544 [TBL] [Abstract][Full Text] [Related]
29. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes. Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071 [TBL] [Abstract][Full Text] [Related]
30. Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome. Cameron B; Flamand L; Juwana H; Middeldorp J; Naing Z; Rawlinson W; Ablashi D; Lloyd A J Med Virol; 2010 Oct; 82(10):1684-8. PubMed ID: 20827765 [TBL] [Abstract][Full Text] [Related]
31. Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment. Miller CS; Avdiushko SA; Kryscio RJ; Danaher RJ; Jacob RJ J Clin Microbiol; 2005 May; 43(5):2173-80. PubMed ID: 15872238 [TBL] [Abstract][Full Text] [Related]